Passenger Deletions Generate Therapeutic Vulnerabilities in Cancer
Established the principle of “collateral lethality” and identified ENO2 as a target for therapeutic intervention by demonstrating that ENO2-depleation selectively inhibited growth, survival and the tumorigenic potential of ENO1-deleted GBM cells. Read the Abstract Download the PDF
Passenger Deletions Generate Therapeutic Vulnerabilities in Cancer Read More »